Fisher Paykel (Australia) Today
| FPH Stock | 34.39 0.87 2.60% |
Performance4 of 100
| Odds Of DistressLess than 9
|
Fisher Paykel is selling for under 34.39 as of the 25th of November 2024; that is 2.60 percent increase since the beginning of the trading day. The stock's last reported lowest price was 33.54. Fisher Paykel has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Fisher Paykel Healthcare are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Fisher Paykel is entity of Australia. It is traded as Stock on AU exchange. The company has 583.98 M outstanding shares. More on Fisher Paykel Healthcare
Fisher Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fisher Paykel's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fisher Paykel or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO MD | Lewis Gradon | ||||
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Management, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
Fisher Paykel's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Fisher Paykel's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsFisher Paykel can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Fisher Paykel's financial leverage. It provides some insight into what part of Fisher Paykel's total assets is financed by creditors.
| |||||
Fisher Paykel Healthcare (FPH) is traded on Australian Securities Exchange in Australia and employs 6,978 people. Fisher Paykel is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 20.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fisher Paykel's market, we take the total number of its shares issued and multiply it by Fisher Paykel's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fisher Paykel Healthcare operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 583.98 M outstanding shares.
Fisher Paykel generates positive cash flow from operations, but has no cash available
Check Fisher Paykel Probability Of Bankruptcy
Ownership AllocationFisher Paykel holds a total of 583.98 Million outstanding shares. 30% of Fisher Paykel Healthcare outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fisher Ownership Details
Fisher Paykel Healthcare Risk Profiles
Although Fisher Paykel's alpha and beta are two of the key measurements used to evaluate Fisher Paykel's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.1 | |||
| Semi Deviation | 1.39 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.07 |
Fisher Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fisher Paykel without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Fisher Paykel Corporate Management
Elected by the shareholders, the Fisher Paykel's board of directors comprises two types of representatives: Fisher Paykel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fisher. The board's role is to monitor Fisher Paykel's management team and ensure that shareholders' interests are well served. Fisher Paykel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fisher Paykel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hayden Brown | Head Relations | Profile | |
| Nicola Talbot | Vice Resources | Profile | |
| Raelene Leonard | Company Counsel | Profile | |
| Andrew Somervell | Vice Technology | Profile | |
| Lyndal York | Chief Officer | Profile | |
| Paul BCom | Senior Marketing | Profile |
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.